Part 1 of the series: Neonatal Vascular Access: A Practical Guide to PICCs and Midlines
Introduction
Neonatal vascular access decisions are rarely straightforward. Clinicians must balance therapy requirements, anticipated treatment duration, vessel health and future access needs, often in patients with extremely small and fragile veins.
While peripheral intravenous cannulas (PIVCs), Midlines and peripherally inserted central catheters (PICCs) all have a role in neonatal care, selecting the wrong device may increase the likelihood of repeated cannulation, vessel injury, treatment interruption and patient discomfort.
This practical guide provides a structured framework for selecting the most appropriate vascular access device for neonatal patients.
Step 1: Assess the Intended Therapy
The first question should not be which device is easiest to insert, but rather:
What therapy does this patient need?
Treatment requirements should drive device selection.
Peripheral-compatible therapy
A PIVC or Midline may be appropriate when therapy consists of:
- Non-vesicant medications
- Non-irritant medications
- Peripheral-compatible fluids
- Short-to-intermediate duration therapy
Central therapy
A PICC should be considered when therapy includes:
- Parenteral nutrition
- Hyperosmolar solutions
- Multiple continuous infusions
- Therapies requiring reliable central venous access
Step 2: Estimate Therapy Duration
Anticipated duration is one of the most important predictors of appropriate device selection.
Therapy expected for ≤5-7 days
Consider: PIVC
Suitable when:
- Treatment is short term
- Reliable peripheral access is available
- No central therapy is required
Therapy expected for 1-4 weeks
Consider: Midline
Suitable when:
- Therapy duration exceeds that typically supported by a peripheral cannula
- Medication remains suitable for peripheral administration
- Multiple cannula replacements are likely
Potential advantages include:
- Reduced re-siting procedures
- Improved patient comfort
- Support for vessel preservation
Therapy expected for >1-2 weeks or central therapy required
Consider: PICC
Suitable when:
- Parenteral nutrition is anticipated
- Long-term therapy is required
- Multiple infusions are necessary
- Venous access is becoming limited
Step 3: Evaluate Vessel Health
Device selection should always include assessment of existing vascular health.
Consider:
- Previous cannulation attempts
- Vein availability
- Quality of available vessels
- Expected future access requirements
Early escalation to an alternative device may be appropriate when repeated peripheral cannulation is likely to compromise future access options.
Step 4: Plan Beyond Today’s Needs
A common error in neonatal vascular access is making decisions solely based on current requirements.
Instead, ask:
- Will treatment extend beyond initial expectations?
- Is another access procedure likely?
- Will additional therapies be required?
- Can future procedures be avoided?
Considering the entire treatment pathway can help preserve veins and reduce procedural burden.
Clinical Decision Guide
Scenario 1
A 35-week infant requires IV antibiotics for four days.
Likely option:
✅ PIVC
Scenario 2
A preterm infant requires 14 days of peripheral-compatible therapy.
Likely option:
✅ Midline
Scenario 3
An infant requires parenteral nutrition and multiple infusions.
Likely option:
✅ PICC
Clinical Takeaways
- Match the device to the therapy.
- Consider anticipated duration early.
- Assess vessel health before device selection.
- Escalate proactively rather than reactively.
- Aim to complete the entire treatment course with the initial device wherever appropriate.
Next Article:
Vessel Preservation in Neonatal Care: A Practical Guide to Protecting Fragile Veins
A place to learn about health procedures and techniques from leading professionals.
